Hot Watch List: BlackBerry Ltd (NASDAQ:BBRY), RF Micro Devices (NASDAQ:RFMD), Canadian Solar Inc. (NASDAQ:CSIQ), Corcept Therapeutics (NASDAQ:CORT)



BlackBerry Ltd (NASDAQ:BBRY) is making good progress in its turnaround. According to a report from RBC Capital Markets, published on May 5, 2014, things are looking much better at the Canadian firm, “with the restructuring achieved” a quarter earlier, and also hardware profitability now “seeming within reach”. BlackBerry Ltd (NASDAQ:BBRY) stock performance was -4.95% in last session and finished the day at $ 7.29. Traded volume was 13,952,218 shares in the last session and the average volume of the stock remained 18,420,000 shares. The beta of the stock remained 0.48. BlackBerry Ltd (NASDAQ:BBRY) insider ownership is 15.01%.

RF Micro Devices (NASDAQ:RFMD)’s CFO William Priddy sold 21,644 shares of the company’s stock on the open market in a transaction dated Monday, May 5th. The stock was sold at an average price of $8.50, for a total transaction of $183,974.00. Following the sale, the chief financial officer now directly owns 563,042 shares in the company, valued at approximately $4,785,857. RF Micro Devices, Inc. (NASDAQ:RFMD) rose 1.48% percent to $ 8.90 yesterday on volume of 12,531,805 shares. The intra-day range of the stock was $ 8.73 – 8.90. RF Micro Devices, Inc. (NASDAQ:RFMD) has a market capitalization of $ 2.52 billion.

Canadian Solar (NASDAQ:CSIQ)’s shares were the recipient of some unusual options trading on Monday. Investors bought 14,169 call options on the company,American Banking and Market News reports. This is an increase of 460% compared to the average volume of 2,528 call options. Canadian Solar Inc. (NASDAQ:CSIQ)’s stock on May 7, 2014 reported a increase of 0.96% to the closing price of $ 27.25. Its fifty two weeks range is $ 5.25 – 44.50. The total market capitalization recorded $1.38 billion. The overall volume in the last trading session was 6,333,456 shares. In its share capital, Canadian Solar Inc.(NASDAQ:CSIQ) has 54.77 million outstanding shares.

Corcept Therapeutics (NASDAQ:CORT) announced its earnings results on Wednesday. The company reported ($0.11) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.09) by $0.02, AmericanBankingNews.com reports. On Friday, shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)dropped -50.50% to close the day at $ 1.99. Company return on investment (ROI) is -74.10% and its monthly performance is recorded as -50.99%. Corcept Therapeutics Incorporated (NASDAQ:CORT)quarterly revenue growth is -34.54%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone